DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Ocular Therapeutix, Inc. 

204 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


SEARCH JOBS










 Company News
Ocular Therapeutix, Inc. (OCUL) To Participate In Two Upcoming Investor Conferences 2/19/2015 12:27:15 PM
Ocular Therapeutix, Inc. (OCUL) To Present At The 17th Annual BIO CEO & Investor Conference 2/5/2015 11:35:12 AM
Ocular Therapeutix, Inc. (OCUL) Enrolls First Patient In Phase 2 Clinical Trial For Sustained Release Dexamethasone For The Treatment Of Dry Eye Disease 1/21/2015 8:13:47 AM
Ocular Therapeutix, Inc. (OCUL) To Present At Oppenheimer 25th Annual Healthcare Conference 12/2/2014 3:10:19 PM
Ora-CAC® Model Provided Platform For Recent Positive Phase 2 Data For Ocular Therapeutix, Inc. (OCUL)’s OTX-DP In Allergic Conjunctivitis 11/24/2014 9:42:08 AM
Ocular Therapeutix, Inc. (OCUL) Enrolls First Patients In Phase 2b Clinical Trial For Sustained Release Travoprost For The Treatment Of Glaucoma And Ocular Hypertension 11/12/2014 10:29:24 AM
Ocular Therapeutix, Inc. (OCUL) Reports Third Quarter 2014 Financial Results 11/12/2014 9:52:55 AM
Ocular Therapeutix, Inc. (OCUL) Announces Top-Line Results From Phase 2 Sustained Release Dexamethasone Trial For Allergic Conjunctivitis 11/12/2014 9:50:59 AM
Ocular Therapeutix, Inc. (OCUL) To Report Third Quarter 2014 Financial Results And Provide Business Updates On Wednesday, November 12, 2014 11/5/2014 10:11:03 AM
Ocular Therapeutix, Inc. (OCUL) To Participate In Two Investor Conferences In November 2014 10/31/2014 9:26:05 AM
12345